Global Pharmaceutical Drug Delivery Market – Insights
Pharmaceutical drug delivery is administering drug in the body for the treatment of a disease or disorder. There are two types of pharmaceutical drug delivery system: conventional drug delivery system and novel drug delivery system. Drug delivery through various routes such as oral, topical, and transmucosal is referred as conventional drug delivery system. The system aids in modifying absorption, distribution, metabolism, and elimination of drugs for the patient’s convenience. Sustained release (SR) drug and controlled release drug are a part of novel drug delivery system. SR demonstrates slow release of drug, where as in controlled release, the speed of drug release is regulated. These aid in maintaining drug level in the blood and in enhancing targeted drug release.
Increasing drug approval to augment growth of the global pharmaceutical drug delivery market
Major regulatory bodies are focused on approving novel drugs, which is expected to boost growth of the global pharmaceutical drug delivery market. For instance, in April 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Ortho Dermatogics’ Duobrii (contains-halobetasol propionate and tazarotene), which is used for the treatment of plaque psoriasis.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/2633
Moreover, increasing launch of new products is also expected to propel growth of the market. For instance, in August 2018, Sanofi Genzyme launched new drug (Aubagio) – a once-a-day therapy for the treatment of multiple sclerosis. In April 2019, Pfizer launched trastuzumab (trazimera) for the treatment of metastatic HER2 (Human Epidermal Growth Factor2)-positive breast cancer and HER2-positive metastatic gastric cancer.
Drug shortage to hinder growth of the global pharmaceutical drug delivery market
A major factor hindering growth of the market is drug shortage. For instance, according New York Times report in February 2019, Buspirone HCL Tablets -7.5mg manufactured by Accord Healthcare Inc. was on shortage, due to high demand for the drug for the anxiety treatment.
Moreover, ban of drugs is also expected to hamper the global pharmaceutical drug delivery market. For instance, in September 2018, Union Health Ministry of India banned 328 FDC (Fixed Dose Composition) drugs due to irrational use of FDC drugs. Some other examples of banned drugs are Aceclofenac (SR) + Paracetamol 750, Aceclofenac + Paracetamol + Famotidine, and naproxen plus paracetamol.
North America to hold dominant position in the market
North America is expected to account for the largest market share in the global pharmaceutical drug delivery market over the forecast period. This is attributed to increasing R&D of new drugs in the region. For instance, in April 2019, Abbvie Pharmaceutical received an approval from the U.S. FDA for SKYRIZI (risankizumab), which is used for the treatment of Plaque Psorisis.
Get Discount For First Time Buyers
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2633
Increasing launch of new drugs is expected to boost growth of the market in Asia Pacific. For instance, in April 2019, Glenmark launched its anti-diabetic medicine – SGLT2 inhibitor Remogliflozin (oral route of administration) in India for the treatment of type-2 diabetes mellitus in adults.
Global Pharmaceutical Drug Delivery Market: Competitive Landscape
Major players operating in the global pharmaceutical drug delivery market include Bayer AG, Pfizer, Inc., Novartis AG, Johnson and Johnson, Merck & Co, Inc., Sanofi, Antares Pharma, Inc., Accord Healthcare, Inc., Abbott, and GSK.
Global Pharmaceutical Drug Delivery Market-Taxonomy
By Route of Administration
- Oral Drug Delivery
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-Solid Oral Drugs
- Topical Drug Delivery
- Liquid Formulation
- Semi-Solid Formulation
- Solid Formulation
- Transdermal Products
- Pulmonary Drug Delivery
- Metered-Dose Inhalers
- Dry Powder Inhalers
- Nasal Drug Delivery
- Nasal Drops
- Nasal Sprays
- Nasal Powders
- Nasal Gels
- Transmucosal Drug Delivery
- Oral Formulations
- Injectable Drug Delivery
- Conventional Injection Devices
- Self-Injection Devices
- Ocular Drug Delivery
- Liquid Formulations
- Semi-Solid Formulations
- Ocular Devices
- Implantable Drug Delivery
- Active Implantable Drug Delivery
- Passive Implantable Drug Delivery
- Infectious Diseases
- Cardiovascular Diseases
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Ambulatory Surgical Centers/ Clinics
- Diagnostic Centers
- North America
- Asia Pacific
- Latin America
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027